Afatinib Terminated Phase 1 Trials for Metastatic Disease Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01679405BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer